BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8016741)

  • 1. [The prognosis of the disease course in patients with hypertension and coronary failure].
    Iureneev AP; Gerashchenko IuS; Dubov PB
    Ter Arkh; 1994; 66(4):9-11. PubMed ID: 8016741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology of the hypertensive heart].
    Middeke M
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S253-6. PubMed ID: 19085801
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risk of cardiovascular complications in patients with frequent hypertensive crises].
    Kolos IP; Chazova IE; Tereshchenko SN; Nakonechnikov SN
    Ter Arkh; 2009; 81(9):9-12. PubMed ID: 19827644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up.
    Saadeh AM; Jones JV
    J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac failure in hypertensive cardiopathy].
    Verdecchia P
    Ital Heart J; 2000 Jun; 1 Suppl 2():72-7. PubMed ID: 10905132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular longitudinal systolic dysfunction is an independent marker of cardiovascular risk in patients with hypertension.
    Ballo P; Barone D; Bocelli A; Motto A; Mondillo S
    Am J Hypertens; 2008 Sep; 21(9):1047-54. PubMed ID: 18670417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy as a risk factor in hypertension.
    Balogun MO; Dunn FG
    Afr J Med Med Sci; 1996 Sep; 25(3):277-83. PubMed ID: 10457806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of an overall coronary bed affection in heart remodeling in patients with stenocardia and arterial hypertension].
    Dmitriev VL; Volkova EG; Levashov SIu
    Ter Arkh; 2002; 74(4):53-5. PubMed ID: 12043241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors in stable coronary disease. Relationship with ischemic threshold and prognostic implications].
    Salcedo A; Echevarría P; Molinero E; Sagastagoitia D; Aguirre JM; Iriarte MM; Laka Mugarza JP
    Med Clin (Barc); 1996 Mar; 106(10):372-7. PubMed ID: 8637276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities.
    Mondillo S; Agricola E; Ammaturo T; Guerrini F; Barbati R; Focardi M; Picchi A; Ballo P; Nami R
    Can J Cardiol; 2001 May; 17(5):571-7. PubMed ID: 11381279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiopathologic introduction to anesthesia and resuscitation of the vascular patient].
    Coriat P
    J Mal Vasc; 1998 Feb; 23(1):35-40. PubMed ID: 9551351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertrophy of the left ventricle--etiopathogenesis, clinical consequences and prognosis].
    Ghanem Wisam MA; Murín J; Bulas J
    Vnitr Lek; 1999 Jul; 45(7):421-8. PubMed ID: 11045162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiac hypertrophy in hypertension--clinical significance and possibilities of control].
    Widimský J
    Cor Vasa; 1993; 35(2):84-9. PubMed ID: 8500300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension, left ventricular hypertrophy and heart failure].
    Mancia G; Giannattasio C; Grassi G
    Ann Ital Med Int; 1993 Oct; 8 Suppl():5S-8S. PubMed ID: 8117522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension and heart disease].
    Gerdts E; Omvik P; Mo R; Kjeldsen SE
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):802-5. PubMed ID: 15039815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.